These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients. Brassier A; Gobin S; Arnoux JB; Valayannopoulos V; Habarou F; Kossorotoff M; Servais A; Barbier V; Dubois S; Touati G; Barouki R; Lesage F; Dupic L; Bonnefont JP; Ottolenghi C; De Lonlay P Orphanet J Rare Dis; 2015 May; 10():58. PubMed ID: 25958381 [TBL] [Abstract][Full Text] [Related]
23. 1H MRS allows brain phenotype differentiation in sisters with late onset ornithine transcarbamylase deficiency (OTCD) and discordant clinical presentations. Gropman AL; Seltzer RR; Yudkoff M; Sawyer A; VanMeter J; Fricke ST Mol Genet Metab; 2008 May; 94(1):52-60. PubMed ID: 18262815 [TBL] [Abstract][Full Text] [Related]
24. Maternal ornithine transcarbamylase deficiency, a genetic condition associated with high maternal and neonatal mortality every clinician should know: A systematic review. Torkzaban M; Haddad A; Baxter JK; Berghella V; Gahl WA; Al-Kouatly HB Am J Med Genet A; 2019 Oct; 179(10):2091-2100. PubMed ID: 31441224 [TBL] [Abstract][Full Text] [Related]
25. Efficient hepatocyte differentiation of primary human hepatocyte-derived organoids using three dimensional nanofibers (HYDROX) and their possible application in hepatotoxicity research. Tong Y; Ueyama-Toba Y; Yokota J; Matsui H; Kanai M; Mizuguchi H Sci Rep; 2024 May; 14(1):10846. PubMed ID: 38736008 [TBL] [Abstract][Full Text] [Related]
26. An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency. Scaglia F; Zheng Q; O'Brien WE; Henry J; Rosenberger J; Reeds P; Lee B Pediatrics; 2002 Jan; 109(1):150-2. PubMed ID: 11773558 [TBL] [Abstract][Full Text] [Related]
27. Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylase deficiency. Wakiya T; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Ushijima K; Otomo S; Sakamoto K; Murayama K; Takayanagi M; Hakamada K; Yasuda Y; Mizuta K Mol Genet Metab; 2012 Mar; 105(3):404-7. PubMed ID: 22264779 [TBL] [Abstract][Full Text] [Related]
28. Functional Analysis of Induced Human Ballooned Hepatocytes in a Cell Sheet-Based Three Dimensional Model. Gao B; Sakaguchi K; Ogawa T; Kagawa Y; Kubo H; Shimizu T Tissue Eng Regen Med; 2021 Apr; 18(2):217-224. PubMed ID: 33517537 [TBL] [Abstract][Full Text] [Related]
29. A new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation. Tarasenko TN; Rosas OR; Singh LN; Kristaponis K; Vernon H; McGuire PJ PLoS One; 2015; 10(2):e0116594. PubMed ID: 25647322 [TBL] [Abstract][Full Text] [Related]
30. Kernicterus in a boy with ornithine transcarbamylase deficiency: A case report. López-Corella E; Ibarra-González I; Fernández-Lainez C; Rodríguez-Weber MÁ; Guillén-Lopez S; Belmont-Martínez L; Agüero-Linares D; Vela-Amieva M Neuropathology; 2017 Dec; 37(6):586-590. PubMed ID: 28815739 [TBL] [Abstract][Full Text] [Related]
31. Histopathological findings in livers of patients with urea cycle disorders. Yaplito-Lee J; Chow CW; Boneh A Mol Genet Metab; 2013 Mar; 108(3):161-5. PubMed ID: 23403242 [TBL] [Abstract][Full Text] [Related]